No black box warning on record for Metopirone

As of the latest FDA labeling reviewed, Metopirone (METYRAPONE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Metopirone medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Adrenal Insufficiency: May induce acute adrenal insufficiency. Ability of adrenals to respond to exogenous ACTH should be demonstrated before Metopirone is employed as a test ( 5.1 ) Dizziness and Sedation: May cause dizziness and sedation. Patients should not drive or operate machinery until these effects have passed ( 5.2 ) 5.1 Adrenal Insufficiency Metopirone may indu

No black box warning on record for Metopirone

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Adrenal Insufficiency: May induce acute adrenal insufficiency. Ability of adrenals to respond to exogenous ACTH should be demonstrated before Metopirone is employed as a test ( 5.1 ) Dizziness and Sedation: May cause dizziness and sedation. Patients should not drive or operate machinery until these effects have passed ( 5.2 ) 5.1 Adrenal Insufficiency Metopirone may indu

Metopirone Black Box Warning

No black box warning on record for Metopirone

Other warnings & precautions

Metopirone Black Box Warning

No black box warning on record for Metopirone

Other warnings & precautions